Funder: Foundation for Women's Cancer
Due Dates: October 7, 2026 (LOI) | December 9, 2026 (Full proposal)
Funding Amounts: $50,000 for one year
Summary: Supports accessible, minimally invasive, cost-effective approaches to early detection of gynecologic cancers other than ovarian cancer.
Key Information: Research must take place at a U.S. institution, with SGO membership, a member co-investigator, or documented member sponsorship.
Description
The Foundation for Women's Cancer (FWC) offers this grant within the Multi-Type Gynecologic Cancer Grants category of its 2026–2027 research funding program. Supported by the family of Peggy A. Yates, it funds innovative research advancing early detection of gynecologic cancers other than ovarian cancer through minimally invasive, accessible, and cost-effective approaches.
Priority goes to discovery and validation of diagnostic biomarkers using readily obtainable biospecimens, including urine, vaginal or cervical samples, and blood, as well as emerging sampling technologies. The goal is to develop accurate, scalable screening strategies that enable earlier diagnosis and can be broadly implemented across diverse populations and care settings.
